ATE363271T1 - Verfahren zur verbesserung der grösse und des aussehens einer wunde - Google Patents

Verfahren zur verbesserung der grösse und des aussehens einer wunde

Info

Publication number
ATE363271T1
ATE363271T1 AT01918824T AT01918824T ATE363271T1 AT E363271 T1 ATE363271 T1 AT E363271T1 AT 01918824 T AT01918824 T AT 01918824T AT 01918824 T AT01918824 T AT 01918824T AT E363271 T1 ATE363271 T1 AT E363271T1
Authority
AT
Austria
Prior art keywords
inhibitor
appearance
improving
size
wound
Prior art date
Application number
AT01918824T
Other languages
English (en)
Inventor
Mary Capelli-Schellpfeffer
Original Assignee
Avocet Polymer Technologies In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avocet Polymer Technologies In filed Critical Avocet Polymer Technologies In
Application granted granted Critical
Publication of ATE363271T1 publication Critical patent/ATE363271T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Lighting Device Outwards From Vehicle And Optical Signal (AREA)
AT01918824T 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde ATE363271T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19019800P 2000-03-17 2000-03-17

Publications (1)

Publication Number Publication Date
ATE363271T1 true ATE363271T1 (de) 2007-06-15

Family

ID=22700387

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01918824T ATE363271T1 (de) 2000-03-17 2001-03-16 Verfahren zur verbesserung der grösse und des aussehens einer wunde

Country Status (7)

Country Link
US (1) US20020013300A1 (de)
EP (1) EP1278517B1 (de)
AT (1) ATE363271T1 (de)
CA (1) CA2406024C (de)
DE (1) DE60128673D1 (de)
ES (1) ES2290120T3 (de)
WO (1) WO2001070210A2 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR038957A1 (es) * 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
JP4868687B2 (ja) * 2002-09-30 2012-02-01 帝國製薬株式会社 ケロイド等の形成抑制外用剤
CA2536357A1 (en) 2003-05-29 2004-12-23 The Scripps Research Institute Targeted delivery to legumain-expressing cells
WO2005009342A2 (en) * 2003-07-16 2005-02-03 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
US20050106221A1 (en) * 2003-11-14 2005-05-19 Nash Alan E. Kit for the treatment of a corn or a callus
US8062661B2 (en) * 2003-12-11 2011-11-22 Teikoku Pharma Usa, Inc. Methods and compositions for treating skin wounds
EP1716854A4 (de) * 2004-02-16 2010-01-20 Teikoku Seiyaku Kk Äusserlich anzuwendende zubereitung zur behandlung schmerzhafter hautwunden
EP3173072A1 (de) 2004-10-01 2017-05-31 Ramscor, Inc. Einfach implantierbare wirkstoffzusammensetzungen mit verzögerter freisetzung
WO2006116661A2 (en) * 2005-04-27 2006-11-02 Avocet Polymer Technologies, Inc. Polyethylene glycol based composition for topical treatment of a closed wound with therapeutic pharmaceuticals
AU2006274530B2 (en) * 2005-08-01 2009-03-12 Hawk Medical Technologies Ltd. Eradication of pigmentation and scar tissue
DE102005055497A1 (de) 2005-11-18 2007-05-31 Stockhausen Gmbh Geruchsbindende superabsorbierende Zusammensetzung
WO2007120687A2 (en) * 2006-04-11 2007-10-25 Avocet Polymer Technologies, Inc. Combination therapy for the treatment and improvement of scars
EP3536350B1 (de) * 2006-08-03 2024-12-18 The Board of Trustees of the Leland Stanford Junior University Bandagen zur behandlungen bzw. prävention von narben und/oder keloiden sowie verfahren und kits dafür
HU227970B1 (en) * 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
US9358009B2 (en) 2007-08-03 2016-06-07 Neodyne Biosciences, Inc. Skin straining devices and methods
US20120226306A1 (en) 2011-03-03 2012-09-06 Jasper Jackson Controlled strain skin treatment devices and methods
US9248048B2 (en) 2007-08-03 2016-02-02 Neodyne Biosciences, Inc. Wound or skin treatment devices and methods
DE102007045724B4 (de) 2007-09-24 2012-01-26 Evonik Stockhausen Gmbh Superabsorbierende Zusammensetzung mit Tanninen zur Geruchskontrolle, Verfahren zu deren Herstellung und Verwendung
TWI455973B (zh) * 2008-03-05 2014-10-11 Evonik Degussa Gmbh 用於氣味控制的具有水楊酸鋅的超吸收性組合物
RU2382763C2 (ru) * 2008-05-26 2010-02-27 Государственное образовательное учреждение высшего профессионального образования "Волгоградский государственный медицинский университет Федеральное агентство по здравоохранению и социальному развитию" Способ усиления пролонгированного жаропонижающего действия и снижения токсичности салицилатов
CN102223889A (zh) * 2008-08-29 2011-10-19 南希·约瑟芬·波利克 顺势疗法的治疗方法
US20100274205A1 (en) * 2009-04-24 2010-10-28 Morelli Rocco R Wound care kit
BR122020025483B1 (pt) 2009-08-11 2021-11-23 Neodyne Biosciences, Inc Dispositivo de tratamento
US10022335B2 (en) 2011-03-03 2018-07-17 Nancy Josephine Polich Homeopathic therapeutic method and compositions
US10561359B2 (en) 2011-12-02 2020-02-18 Neodyne Biosciences, Inc. Elastic devices, methods, systems and kits for selecting skin treatment devices
US10213350B2 (en) 2012-02-08 2019-02-26 Neodyne Biosciences, Inc. Radially tensioned wound or skin treatment devices and methods
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045965B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
CN107249574A (zh) * 2014-09-30 2017-10-13 重庆民济医疗器械有限公司 水凝胶组合物、其制备方法及其应用
EP4072439A4 (de) 2019-12-10 2023-12-13 Neodyne Biosciences, Inc. Vorrichtungen und verfahren zur behandlung von injektions- und infusionsstellen
US20220379018A1 (en) 2019-12-10 2022-12-01 Neodyne Biosciences, Inc. Tensioned infusion systems with removable hubs

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2113374A (en) * 1936-02-18 1938-04-05 Colgate Palmolive Peet Co Salicylic acid derivatives
US3119739A (en) * 1961-05-03 1964-01-28 Wanda L Campbell Acetylmethyl-salicylate for pain relief
US3419006A (en) * 1966-08-08 1968-12-31 Union Carbide Corp Novel dressing and use thereof
US3664343A (en) * 1969-10-06 1972-05-23 Union Carbide Corp Disposable articles
US3800792A (en) * 1972-04-17 1974-04-02 Johnson & Johnson Laminated collagen film dressing
US3993551A (en) * 1973-09-10 1976-11-23 Union Carbide Corporation Process for cocrosslinking water soluble polymers and products thereof
US4126681A (en) * 1975-12-08 1978-11-21 The Procter & Gamble Company Topical composition containing acetyl salicylic acid
DE2707537A1 (de) * 1976-02-23 1977-08-25 Barnes Hind Pharm Inc Praeparat zur lokalbehandlung der hypertrophischen narbenbildung bei akne
US4244948A (en) * 1979-05-07 1981-01-13 Allergan Pharmaceuticals, Inc. Medical use of esters of acetylsalicylic acid to treat acne
US4346108A (en) * 1981-06-22 1982-08-24 The Upjohn Manufacturing Company M Method for preventing adhesion formation
DE3224382A1 (de) * 1982-06-30 1984-01-12 Beiersdorf Ag, 2000 Hamburg Verbandmaterial auf hydrogelbasis und verfahren zu dessen herstellung
IT1169978B (it) * 1983-12-13 1987-06-03 Bella Agatina Di Preparato per la cura delle ustioni
US4659700A (en) * 1984-03-02 1987-04-21 Johnson & Johnson Products, Inc. Chitosan-glycerol-water gel
GB2192142B (en) * 1986-07-04 1990-11-28 Johnson & Johnson Wound dressing
US4646730A (en) * 1986-05-23 1987-03-03 Johnson & Johnson Products, Inc. Color stabilized hydrogel dressing and process
US4909244B1 (en) * 1986-11-26 1994-07-05 Kendall & Co Hydrogel wound dressing
FR2618337B1 (fr) * 1987-07-22 1989-12-15 Dow Corning Sa Pansement chirurgical et procede pour le fabriquer
US5013769A (en) * 1988-08-22 1991-05-07 Medipro Sciences Limited Method of making a hydrogel-forming wound dressing or skin coating material
US5521087A (en) * 1989-05-10 1996-05-28 Massachusetts Institute Of Technology Method for producing oriented connective tissue cells in a ligament configuration
US5132119A (en) * 1989-07-31 1992-07-21 Massachusetts Institute Of Technology Treatment of hypertrophic wound healing disorders with calcium channel blockers
US5569678A (en) * 1989-07-31 1996-10-29 Massachusetts Institute Of Technology Control of wound scar production
US5552162A (en) * 1993-02-09 1996-09-03 Arch Development Corporation Method for improvement of scar size and appearance
WO1998007425A1 (en) * 1996-08-21 1998-02-26 Smithkline Beecham Corporation Imidazole compounds, compositions and use
PL198975B1 (pl) * 1999-04-22 2008-08-29 Biogen Idec Inc Zastosowanie kompozycji zawierającej homolog przeciwciała, który jest antagonistą interakcji między integryną niosącą podjednostkę alfa 4 a jej ligandem
AU7880700A (en) * 1999-08-16 2001-03-13 Dung Phan Compositions and methods of treatment for skin conditions using extracts of turmeric

Also Published As

Publication number Publication date
DE60128673D1 (de) 2007-07-12
WO2001070210A2 (en) 2001-09-27
WO2001070210A3 (en) 2002-10-24
CA2406024C (en) 2012-05-22
CA2406024A1 (en) 2001-09-27
ES2290120T3 (es) 2008-02-16
EP1278517A2 (de) 2003-01-29
EP1278517B1 (de) 2007-05-30
US20020013300A1 (en) 2002-01-31

Similar Documents

Publication Publication Date Title
DE60128673D1 (de) Verfahren zur verbesserung der grösse und des aussehens einer wunde
EE200200328A (et) Multši kompositsioon ja meetod
DE60014180D1 (de) Zubereitung zur verbesserung der epithelialen lipidbarrierefunktion
DE60109164D1 (de) Verfahren und zusammensetzungen zur schmerzbehandlung der schleimhaut
WO2002091999A3 (en) Treatment for wounds
KR20010012902A (ko) 피부 보호 조성물 및 피부 외관의 개선 방법
PT991619E (pt) Inibidores da adesao celular mediada pela alfa4beta1
DE69525847D1 (de) Zusammensetzungen von opioid antagonisten mit selektiven serotonin-aufnahme inhibitoren, zur behandlung von alkoholismus und alkohoabhängigkeit
DK1596880T3 (da) Fremgangsmåder og sammensætninger til undertrykkelse af fibrocytdifferentiering
ID24421A (id) Biosida logam/tiol
ATE371475T1 (de) Methoden zur behandlung der hautpigmentierung
WO2006119283A3 (en) Anti-odor compositions and therapeutic use
NZ531404A (en) Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
DE60235545D1 (de) Verfahren zur behandlung von nagelpilz und anderen mikrobiellen und mykotischen erkrankungen und dafür geeignete zusammensetzungen
DK1411916T3 (da) Fremgangsmåder og materialer til behandling af testosteronmangel hos mænd
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
WO2007005720A3 (en) Methods and compositions for promoting wound healing
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
EE200300305A (et) Geelkompositsioon ja kompositsiooni transskrotaalne kasutamine hüpogonadismi raviks
DE60118882D1 (de) Verwendung des dheas oder bestimmte seiner derivaten zur verbesserung des papyrus-ähnliches aussehens der haut
SI1575383T1 (sl) Vlažen sestavek njuhanca, ki obsega vsaj eno zgoščevalno sredstvo in postopek za njegovo izdelavo
BR0111785A (pt) Composições e métodos para tratamento de candidìase
DE60226313D1 (de) Verwendung von sesquiterpene enthaltenden zusammenstellungen zur behandlung von krebs
ATE396177T1 (de) Neue kristalline formen eines faktor xa inhibitors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties